Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés. View in English

El DUB revela una vulnerabilidad ligada al X en la enfermedad de Alzheimer

  • 0Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Lieber Institute for Brain Development, Baltimore, MD 21205, USA.

|

|

Resumen

Este resumen es generado por máquina.

Mujeres

Área De La Ciencia

  • La neurociencia
  • La genética
  • La bioquímica

Sus Antecedentes

  • Las mujeres presentan un mayor riesgo de enfermedad de Alzheimer (EA) y otras tauopatías.
  • Los mecanismos biológicos específicos que impulsan este aumento del riesgo siguen siendo en gran medida desconocidos.
  • La agregación de la proteína Tau en enredos neurofibrilares es un sello distintivo de la patología de la EA.

Objetivo Del Estudio

  • Investigar los mecanismos moleculares subyacentes a la mayor prevalencia de la enfermedad de Alzheimer y las tauopatías en las mujeres.
  • Identificar los factores específicos que contribuyen al deterioro del aclaramiento de tau en el cerebro femenino.

Principales Métodos

  • Análisis de la actividad de la deubiquitinasa USP11 en el contexto de la patología tau.
  • Investigación del papel de los genes ligados al X en los mecanismos de las enfermedades neurodegenerativas.
  • Estudios centrados en las vías de depuración de proteínas, específicamente la degradación de tau.

Principales Resultados

  • Se identificó una actividad anormalmente alta de la deubiquitinasa USP11 ligada a X en mujeres.
  • Se demostró que esta actividad elevada de la USP11 afectaba el aclaramiento de la proteína tau.
  • Los hallazgos relacionan la desregulación de la USP11 con la acumulación de ovillos neurofibrilares.

Conclusiones

  • El aumento de la actividad de la deubiquitinasa USP11 en las mujeres contribuye al deterioro del aclaramiento de la tau.
  • Este mecanismo ofrece una posible explicación para el mayor riesgo de enfermedad de Alzheimer y tauopatías en las mujeres.
  • USP11 representa un objetivo terapéutico potencial para mitigar la patología tau en las mujeres.

Videos de Conceptos Relacionados

Alzheimer's Disease: Overview 01:26

628

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Sex-linked Disorders 01:43

102.7K

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.

Y chromosome mutations are called “Y-linked” and only affect males since they alone carry a copy of that chromosome. Mutations to the relatively small Y chromosome can impact male sexual function and secondary sex characteristics. Y-chromosome infertility is a disorder that affects...

X-linked Traits 01:19

55.1K

In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.

One well-studied example of an X-linked trait is...

Alzheimer's Disease: Treatment 01:22

247

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Pedigree Analysis 01:35

84.8K

Overview

A pedigree is a diagram displaying a family’s history of a trait. Analyzing pedigrees can reveal (1) whether a trait is dominant or recessive, (2) the type of chromosome, autosomal or sex, a trait is linked to, (3) genotypes of family members, and (4) probabilities of phenotypes in future generations. For families with a history of autosomal or sex-linked diseases, this information can be crucial to family planning.

Pedigrees Display Family Histories

In various plant and...

Genetic Lingo 01:11

103.8K

Overview

An organism is diploid if it inherits two variants, or alleles, of each gene, one from each parent. These two alleles constitute the genotype for a given gene. The term genotype is also used to refer to an organism’s complete set of genes. A diploid organism with two identical alleles has a homozygous genotype, whereas two different alleles indicates a heterozygous genotype. Observable traits arising from genotypes are called phenotypes, which can also be influenced by...